| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-07 |